# Delivery Order #75N91026F00001

Task Order for Epigenomics Characterization Support to Infinity Biologix

**Buyer:** National Institutes of Health

**Award Amount:** $661,396.00
**Ceiling:** $1,316,704.58

**Awarded:** September 25, 2026
**Period of Performance:** Sep 25, 2026 - Sep 24, 2031

**Identifier:** 75N91026F00001
**NAICS:** 541380

This award is a delivery order under a larger indefinite delivery/indefinite quantity (IDIQ) contract previously held by Infinity Biologix LLC, a company specializing in advanced genomic technologies and genome characterization services. The task order focuses on providing epigenomics characterization support specifically for cancer research, supporting critical efforts by the National Cancer Institute (NCI) to advance understanding of cancer biology through epigenetic analysis. Over a multi-year period, the contract entails delivering specialized laboratory services related to epigenomic data characterization, which is essential for ongoing cancer research and potential therapeutic breakthroughs. The contract was competitively awarded within the framework of an established contract vehicle, ensuring a transparent selection process based on Infinity Biologix's demonstrated expertise. The work is performed at the company's facilities in Piscataway, New Jersey, with a performance period spanning several years, highlighting a long-term commitment to cancer epigenomics research. This task order builds upon the foundational IDIQ agreement that underscores NCI's strategic investment in genomic and epigenomic technologies to accelerate health science advancements. No key subcontractors or additional solicitation details are listed for this specific order.

### Description

TASK ORDER AWARD FOR EPIGENOMICS CHARACTERIZATION SUPPORT FOR CANCER RESEARCH

[View original record](https://www.usaspending.gov/award/CONT_AWD_75N91026F00001_7529_75N91025D00005_7529)
